NCT00005023View on ClinicalTrials.gov

Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 1999

Primary Completion Date

January 31, 2001

Study Completion Date

January 31, 2001

Conditions
Breast CancerLung CancerOvarian Cancer
Interventions
BIOLOGICAL

HER-2/neu peptide vaccine

BIOLOGICAL

sargramostim

Trial Locations (1)

98195

University of Washington School of Medicine, Seattle

All Listed Sponsors
lead

University of Washington

OTHER

NCT00005023 - Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer | Biotech Hunter | Biotech Hunter